MTA1 and prostate cancer: Moreover, the expression of E-cadherin (an epithelial marker) was downregulated along with upregulation of Vimentin (a mesenchymal marker) (Figure 1E), indicating the involvement of MTA1 in epithelial-to-mesenchymal transition (EMT) of prostate cancer cells.